Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 5.31
- Piotroski Score 9.00
- Grade Outperform
- Symbol (ABT)
- Company Abbott Laboratories
- Price $116.13
- Changes Percentage (0.44%)
- Change $0.51
- Day Low $115.95
- Day High $117.28
- Year High $121.64
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
- Last Earnings 09/19/2024
- Ex-Dividend for 5/16 Dividend 10/15/2024
- Dividend Payable 11/15/2024
- Today N/A
- Next Earnings (Estimated) 10/15/2024
- Fiscal Year End N/A
- Average Stock Price Target $128.00
- High Stock Price Target $150.00
- Low Stock Price Target $50.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $3.21
- Trailing P/E Ratio 33.51
- Forward P/E Ratio 33.51
- P/E Growth 33.51
- Net Income $5.72 B
Income Statement
Quarterly
Annual
Latest News of ABT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the respectable shareholder returns
Abbott Laboratories' stock has shown a 40% increase in the last five years, underperforming the market. However, newer shareholders saw a 28% gain in the last twelve months....
By Yahoo! Finance | 2 days ago -
Abbott Laboratories (ABT): A Buzzing AI Health Stock to Add to Your Portfolio
Abbott Laboratories (NYSE:ABT) is a key player in the AI-driven healthcare industry, utilizing AI in diagnostics for improved patient outcomes. The growing AI market in healthcare is transforming the ...
By Yahoo! Finance | 1 week ago -
Abbott Laboratories (ABT): 69 Hedge Fund Holders and Strong Wall Street Support
A list of top healthcare stocks recommended by hedge funds includes Abbott Laboratories (NYSE: ABT). With a strong market presence and innovative medical devices in diabetes and cardiovascular health,...
By Yahoo! Finance | 1 week ago
